Medical devices, healthcare technology and the business of care
510(k) clearance · K261079

Power Wheelchair (DC12)

Anhui JBH Medical Apparatus Co., Ltd. · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONK261079

What did the FDA decide?

FDA recorded a substantially equivalent decision for K261079, a traditional 510(k) for the device named Power Wheelchair (DC12), submitted by Anhui JBH Medical Apparatus Co., Ltd. of Chuzhou, China. The decision date is 06 October 2026, with the application received 01 April 2026. The regulation number is 890.3860, the classification product code is ITI, and the review panel and medical specialty are both Physical Medicine. Substantial equivalence is a clearance finding, not premarket approval of the device.

The public record does not identify a predicate device, summarize the technological comparison, or describe any specific component, changed item or testing submitted in the application. It also records that the review was not conducted by a third party, that the submission was not a combination product, and that no predetermined change control plan was authorized. The same FDA listing shows separate clearances for other Anhui JBH power wheelchairs, including K261200 (D60) and K261169 (D39), but the record does not state how those submissions relate to K261079.

Clinical performance, labeling and indications for the DC12 are not established by this record; those details would reside in the underlying submission, which is not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Oct 6, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261079
Regulatory pathway
510(k) premarket notification
Product code
ITI
Decision code
SESE
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wheelchair, Powered.

Product code
ITI
FDA device class
2

FDA decision timeline

  1. K261079 received

    Application receipt date recorded by FDA.

  2. K261079 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code ITI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Anhui JBH Medical Apparatus Co., Ltd.

Headquarters
Not reported
Brand website
jbhmedical.com
FDA applicant address
Chuzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records